Araceli Biosciences closes $11M seed round

Araceli Biosciences closes $11M seed round

Drug discovery tech startup Araceli Biosciences will use its fresh capital to scale operations to meet growing demand.

Araceli Biosciences Closes $11.2M Seed Financing

Araceli Biosciences, a Portland, OR-based biotechnology company for high-content imaging and AI-powered analysis, raised $11.2M in Seed funding. Bill Cortelyou, Board Chairman, was the lead investor.   The company intends to use the funds to: Led by CEO Matt Beaudet, Araceli Biosciences is a biotechnology company focused on accelerating drug discovery through innovations in high-content […] The post Araceli Biosciences Closes $11.2M Seed Financi…

Araceli Biosciences Closes $11.2M Seed Financing to Change the Pace of Drug Discovery - Araceli Biosciences

Araceli Biosciences Closes $11.2M Seed Financing to Change the Pace of Drug Discovery PORTLAND, Ore., April 24, 2025 — Araceli Biosciences, a pioneering biotechnology company revolutionizing high-content imaging and AI-powered analysis, today announced the successful completion of its Seed funding round, raising $7.2 million in new equity investment and converting $4.0 million in SAFEs, bringing total financing since Araceli’s spinout from…